Kavita Juneja
Company: Corcept Therapeutics
Job title: Senior Director & Head of Metabolic Therapeutic Development
Seminars:
4:25 pm Roundtable Discussion: Optimizing Patient Selection to Improve MASH Trial Outcomes for Global Treatment Success 4:25 pm
Emphasizing the necessity of incorporating non-invasive tests (NITs) to complement or potentially replace liver biopsies in MASH clinical trials, especially in global settings, to improve patient comfort, reduce screening failures, and enhance the feasibility of large-scale studies Highlighting the importance of addressing the heterogeneity of MASH across different ethnicities and geographical regions by employing tailored…Read more
day: Conf Day 1